Cargando…
Regulation of Transplanted Cell Homing by FGF1 and PDGFB after Doxorubicin Myocardial Injury
There is no effective treatment for the total recovery of myocardial injury caused by an anticancer drug, doxorubicin (Dox). In this study, using a Dox-induced cardiac injury model, we compared the cardioprotective effects of ventricular cells harvested from 11.5-day old embryonic mice (E11.5) with...
Autores principales: | Baguma-Nibasheka, Mark, Feridooni, Tiam, Zhang, Feixiong, Pasumarthi, Kishore B.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616453/ https://www.ncbi.nlm.nih.gov/pubmed/34831221 http://dx.doi.org/10.3390/cells10112998 |
Ejemplares similares
-
Cardiomyocyte Specific Ablation of p53 Is Not Sufficient to Block Doxorubicin Induced Cardiac Fibrosis and Associated Cytoskeletal Changes
por: Feridooni, Tiam, et al.
Publicado: (2011) -
Ultrastructural and immunocharacterization of undifferentiated myocardial cells in the developing mouse heart
por: Zhang, Feixiong, et al.
Publicado: (2007) -
Assessment of embryonic myocardial cell differentiation using a dual fluorescent reporter system
por: McMullen, Nichole M, et al.
Publicado: (2009) -
Characterizing the role of atrial natriuretic peptide signaling in the development of embryonic ventricular conduction system
por: Govindapillai, Arun, et al.
Publicado: (2018) -
Alternative splicing and differential subcellular localization of the rat FGF antisense gene product
por: Zhang, Shuo Cheng, et al.
Publicado: (2008)